Autoimmune Hepatitis Cohort in China

Recruiting now

Conditions studied: Autoimmune Hepatitis

In brief

The goal of this observational study is to describe the clinical features and long-term prognosis in patients diagnosed with autoimmune hepatitis (AIH) in China and assess the effectiveness and safety of AIH treatment options in a real-world setting.

Key facts

Study ID

NCT05785793

Run by

Shanghai Jiao Tong University School of Medicine

People needed

1000

Starts

2023-02-01

Expected to finish

2028-02-01

Last updated by the study team

2023-03-28

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 14 years
• Probable or definite diagnosis of autoimmune hepatitis according to the International Autoimmune Hepatitis Study Group criteria
• Availability of all following essential parameters at the initial diagnosis of AIH: including alanine transaminase, aspartate aminotransferase, total bilirubin, alkaline phosphatase, immunoglobulin G, and platelet count
• Provide informed consent

You may not qualify if…

• Have a concomitant diagnosis of primary biliary sclerosis, primary sclerosing cholangitis, immunoglobulin G 4-related cholangitis
• Have an active infection with hepatitis B virus, hepatitis C virus, hepatitis delta virus, HIV, cytomegalovirus, or Epstein-Barr virus
• Have a concomitant diagnosis of hepatocellular carcinoma or other malignant diseases before the diagnosis of AIH
• Considered ineligible to the enrollment in the clinical study by the researcher

Where it is running

• Renji Hospital, School of Medicine, Shanghai Jiao Tong University — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.